Form D · Biotechnology
FYR Diagnostics, Inc.
Missoula, MT · CIK 0002033993
Offering snapshot reported Aug 16, 2024 · SEC filing
- Reported sold
- $8M Offering amount: $12M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 16, 2024 | Initial | $8,002,176 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521806
Preferred stock, and any common stock issuable upon its conversion
Source: Form D, filed Aug 16, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Booth | Director, Executive |
| Brian Conway | Executive |
| Michael Goguen | Director |
| Sarjubhai Patel | Director, Executive |
| Avery Sonnenberg | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1121 E Broadway Street
Missoula, MT, 59802
Missoula, MT, 59802